Skip Content
You are currently on the new version of our website. Access the old version .
CellsCells
  • Article
  • Open Access

29 July 2020

iPS-Derived Early Oligodendrocyte Progenitor Cells from SPMS Patients Reveal Deficient In Vitro Cell Migration Stimulation

,
,
and
1
Laboratory of Cell Reprogramming (LARCEL), Andalusian Centre for Nanomedicine and Biotechnology-BIONAND, 29590 Málaga, Spain
2
Bioinformatics Unit. GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, E-18016 Granada, Spain
3
Atrys Health, 08025 Barcelona, Spain
4
Department of Statistics. University of Granada, 18071 Granada, Spain
This article belongs to the Section Stem Cells

Abstract

The most challenging aspect of secondary progressive multiple sclerosis (SPMS) is the lack of efficient regenerative response for remyelination, which is carried out by the endogenous population of adult oligoprogenitor cells (OPCs) after proper activation. OPCs must proliferate and migrate to the lesion and then differentiate into mature oligodendrocytes. To investigate the OPC cellular component in SPMS, we developed induced pluripotent stem cells (iPSCs) from SPMS-affected donors and age-matched controls (CT). We confirmed their efficient and similar OPC differentiation capacity, although we reported SPMS-OPCs were transcriptionally distinguishable from their CT counterparts. Analysis of OPC-generated conditioned media (CM) also evinced differences in protein secretion. We further confirmed SPMS-OPC CM presented a deficient capacity to stimulate OPC in vitro migration that can be compensated by exogenous addition of specific components. Our results provide an SPMS-OPC cellular model and encouraging venues to study potential cell communication deficiencies in the progressive form of multiple sclerosis (MS) for future treatment strategies.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.